The Liver as Origin and Target of Reactive Intermediates Exemplified by the Progesterone Derivative, Cyproterone Acetate
Since the middle of the last century it is known that chemicals can cause liver injury (cf. Zimmerman, 1978). In 1860, a severe fatty liver in man was ascribed to phosphorous intoxication. During the first half of the 20th century several hepatotoxins have been extensively studied and in the second half of this century it became clear that in many cases enzymatically ‘activated’ metabolites of xenobiotics are responsible for the toxic effects observed (cf. Zimmerman, 1978; Hinson et al., 1994). The liver was found to express the highest concentrations and greatest variety of xenobiotic metabolizing enzymes in the body (cf. Zimmerman, 1978; Watkins, 1990). This high metabolic capacity turned out to be a primary cause of the liver specificity of toxic xenobiotics. Chemically induced liver damage may have three main manifestations (Fig. 1).
KeywordsHuman Hepatocyte Cyproterone Acetate Adduct Level Cytochrome P450 Isoenzyme Synthetic Steroid
Unable to display preview. Download preview PDF.
- Hiimpel, M, Nieuweboer, B., Düsterberg, B. and Wendt, H., 1979, Die Pharmakokinetik von Cyproteronacetat beim Menschen, In Androgenisierungserscheinungen bei der Frau (J. Hammerstein et al., Eds.) Exerpta Medica.Google Scholar
- Kasper, P., Gerhard, A., Kaufmann, G., Madle, H. and Müller, L., 1993, Further investigations into the gentoxicity of cyproterone acetate. Abstract of a poster presented at the 23rd Ann. Meeting of the European Environmental Mutagen Society (EEMS) in Barcelona, 27. Sept.-2. Oct. 1993.Google Scholar
- Lang, R. and Reimann, R. 1993, Studies for a genotoxic potential of some endogenous and exogenous sex steroids. I. Communication: Examination for the induction of gene mutations using the Ames Salmonella / Microsome Test and the HGPRT Test in V79 cells, Environ. Molec. Mutag. 21: 272–304.CrossRefGoogle Scholar
- Mulder, G.J., 1981, Sulfate availability in vivo, In Sulfation of Drugs and Related Compounds (G.J. Mulder, Ed.) pp. 31–52. CRC Press, Boca Raton.Google Scholar
- Pitot, H.C., and Dragan, Y.P., 1994, Chemical induction of hepatic neoplasia, In Liver: Biology and Pathobiology, 3rd edition (I.M. Arias, Ed.), pp. 1467–1498. Raven Press, New York.Google Scholar
- Plaa, G.L., 1991, Toxic responses of the liver, In Casarett and Doull’s Toxicology (C.D. Klaassen, M.O. Amdur, and J. Doull, Eds.), pp. 286–309. Macmillan Publishing Company, New York.Google Scholar
- Schulte-Hermann, R., Ohde, G., Schuppler, J., and Timmermann-Trosiener, I. 1981, Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin, Cancer Res. 41: 2556–2562.PubMedGoogle Scholar
- Schwarz, L.R., and Greim, H., 1986, Environmental chemicals in hepatocarcinogenesis: The mechanism of tumor promoters, In Progress in Liver Diseases, vol. VIII (H. Popper and F. Schaffner Eds.), pp. 581–595. Grune & Stratton, Orlando, New York.Google Scholar
- Steinberg, P., and Oesch, F., 1992, Liver cell specific toxicity of xenobiotics, Tissue Specific Toxicity: Biochemical Mechanisms (W. Dekant and H.-G. Neumann, Eds.), pp. 117–137. Academic Press, London.Google Scholar
- Strom, S.C., Jirtle, R.L., Jones, R.S., Novicki, D.L., Rosenberg, M.R., Novotny, A., Irons, G., McLain, J.R., and Michalopoulos, G. 1982, Isolation, culture and transplantation of human hepatocytes, JNCI, J. Natl. Cancer Inst. 68: 771–778.Google Scholar
- Zimmermann, HJ., 1978, The adverse effects of drugs and other chemicals on the liver,. In Hepatotoxicity. Appleton-Century-Crofts, New York.Google Scholar